(Q37248355)

English

Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan

scientific article published on December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

L C Newman

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

R K Cady

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

S Landy

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

P O'Carroll

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

W J Kwong

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

S P Burch

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A C Nelsen

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

S A McDonald

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

1 December 2008

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

62

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1889-1899

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Review of clinical trials using early acute intervention with oral triptans for migraine management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Treatment strategies in the acute therapy of migraine: stratified care and early intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Sumatriptan: a decade of use and experience in the treatment of migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

The International Classification of Headache Disorders: 2nd edition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

What do patients with migraine want from acute migraine treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Determinants of patient satisfaction with migraine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Impact of migraine in the United States: data from the National Health Interview Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

6 September 2017

Burden of migraine: societal costs and therapeutic opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

28 September 2017

Burden of migraine in the United States: disability and economic costs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

26 June 2018

Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Can migraineurs accurately identify their headaches as "migraine" at attack onset?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

The effect of early intervention with sumatriptan tablets on migraine-associated productivity loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

The family impact and costs of migraine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Costs and outcomes of early versus delayed migraine treatment with sumatriptan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Economic implications of early treatment of migraine with sumatriptan tablets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704938

3 September 2018

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19166436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for controlled trials of drugs in migraine: second edition

1 reference

https://pubmed.ncbi.nlm.nih.gov/19166436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Acute Migraine With Subcutaneous Sumatriptan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19166436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19166436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19166436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1742-1241.2008.01935.X

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37248355&oldid=1697434518"